Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative dexmedetomidine for gastrointestinal recovery after abdominal surgery
IRCT20251011067593N1Phase 3Completed
- Sponsor
- Islamic Azad University, Tehran Medical Sciences Branch
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in Postoperative gastrointestinal dysfunction (POGD) (2 arms), sponsored by Islamic Azad University, Tehran Medical Sciences Branch. Primary endpoints: Time of first gas passage, Time of first oral feeding and 1 more. Started Oct 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on IRCT20251011067593N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251011067593N1.